Skip to content

Effectiveness of a guided mental health chatbot for youth living in Jordan in communities exposed to adversity

Effectiveness of the STARS guided mental health chatbot for youth living in Jordan in communities exposed to adversity - Feasibility study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN19217696
Enrollment
60
Registered
2022-11-02
Start date
2022-11-02
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Common mental disorders

Interventions

(2) emotions (psychoeducation about emotions)
(3) relax (emotion regulation techniques, such as slow breathing)
(4-5) what we do (behavioural activation)
(6-7) managing problems (problem management techniques)
(8-9) self-talk (thought challenging)
and (10) what next (consolidating learnings and planning for the future). In addition, the intervention also encourages the user to practice and apply the skills in their own life, which is supported

Sponsors

World Health Organization
Lead Sponsor
UNSW Sydney
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Any person living in Jordan who can read English or Arabic 2. Is between the ages of 18 and 21 years 3. Is experiencing moderate levels of psychological distress as determined by a score of 20 or above on the Kessler distress scale, 10-item version (K10) 4. Has access to a device for intervention delivery or is willing to use one at a participating centre

Exclusion criteria

Exclusion criteria: 1. Persons under 18 years of age or over 21 years of age 2. People at imminent risk of suicide (as defined by the mhGAP intervention guide)

Design outcomes

Primary

MeasureTime frame
Feasibility of the STARS intervention, including: 1. Recruitment rate recorded as the number of eligible participants who consent to participate in the study 2. Drop-out rates recorded as the number of randomized participants who do not complete the intervention or the post-assessment 3. Number of adverse events and serious adverse events 4. Evaluation of (secondary) outcome measures and estimation of differences across the two groups The above will be supported by qualitative process evaluation interviews to further understand aspects related to implementation.

Secondary

MeasureTime frame
Measured at screening/baseline and week 8 unless noted: 1. Psychological distress (Hopkins Symptom Checklist; HSCL-25) 2. Psychological distress (Kessler Psychological Distress scale; K10) 3. Functioning (WHO Disability Assessment Schedule; WHODAS 2.0) 4. Subjective wellbeing (WHO Well-Being Index; WHO-5) 5. Self-identified problems (Psychological Outcomes Profiles; PSYCHLOPS) 6. Agency (agency subscale of the State Hope Scale; SHS-A) 7. User-satisfaction questionnaire (Client Satisfaction Questionnaire; CSQ-I) [only at post-assessment (8 weeks after baseline)]

Countries

Jordan

Contacts

Public ContactKenneth Carswell
carswellk@who.int+41-22-791-5024

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026